UNITY anticipates the complete 36-week data results of the remaining patients in the second quarter of 2025.

Primary investigator and presenter of the study, Ahmed H. Zedan, MD, PhD from Lillebaelt Hospital - University Hospital of Southern Denmark said: ”Proclarix can be safely used to reduce performed ...

OMNIVISION, a leading global developer of semiconductor technology, including advanced digital imaging, analog, and display solutions, and Biotech Dental, a specialist in the design and manufacture of ...

Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces the appointment of Christoph Korpus, PhD, MBA, as Chief ...

Eligible and interested candidates can apply for IIT Delhi PhD admissions at iitd.ac.in. The direct link and other details ...

Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient population UBX1325 was non-inferior to aflibercept at week 24 (>90% confidenc ...

Concord Biotech Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 17,578.14 Crore) operating in Pharmaceuticals sector. Concord Biotech Ltd. key Products/Revenue ...

As graduate programs lose spots and labs face shutdowns following Trump administration cuts to science funding, students and ...

Novel drug delivery approach that utilizes long-acting injectable microcrystals may enable new options for long-term delivery of contraceptives.

The National Institute of Animal Biotechnology (NIAB) in Hyderabad has released an advertisement for Scientist-E (1 UR) ...

Check the registration dates for IIT Delhi M.Tech admissions for the 2025-26 academic year, along with the eligibility ...